Becton Dickinson and Company

250.70+3.29+1.33%Vol 965.91K1Y Perf 1.05%
Apr 13th, 2021 16:00 DELAYED
BID247.40 ASK253.93
Open246.76 Previous Close247.41
Pre-Market- After-Market250.70
 - -  - -%
Target Price
281.62 
Analyst Rating
Moderate Buy 2.00
Potential %
12.33 
Finscreener Ranking
★+     44.72
Insiders Trans % 3/6/12 mo.
-/-100/-100 
Value Ranking
★+     43.14
Insiders Value % 3/6/12 mo.
-/-100/-100 
Growth Ranking
★★★     53.96
Insiders Shares Cnt. % 3/6/12 mo.
-/-100/-100 
Income Ranking
     34.45
Market Cap72.84B 
Earnings Rating
Neutral
Price Range Ratio 52W %
47.66 
Earnings Date
6th May 2021

Today's Price Range

246.50251.46

52W Range

219.50284.97

5 Year PE Ratio Range

35.80648.50

Summary:

Buy

Technical Indicators: Buy
Moving Averages: Strong Buy
Performance
1 Week
2.74%
1 Month
5.23%
3 Months
-2.74%
6 Months
7.65%
1 Year
1.05%
3 Years
11.24%
5 Years
59.69%
10 Years
236.11%

TickerPriceChg.Chg.%
BDX250.703.29001.33
AAPL134.433.19002.43
GOOG2 267.2712.48000.55
MSFT258.312.40000.94
XOM55.710.21000.38
WFC39.79-0.9800-2.40
JNJ159.48-2.1600-1.34
FB309.76-1.7800-0.57
GE13.44-0.1500-1.10
JPM154.09-1.8600-1.19
Financial StrengthValueIndustryS&P 500US Markets
0.80
1.40
0.39
0.72
4.40
Leverage Ratio 2.20
ProfitabilityValueIndustryS&P 500US Markets
45.80
12.40
24.40
7.30
10.21
RevenueValueIndustryS&P 500US Markets
13.95B
48.02
4.45
7.43
DividendsValueIndustryS&P 500US Markets
1.34
3.32
2.36
4.70
Payout ratio116.00
Earnings HistoryEstimateReportedSurprise %
Q01 20213.144.5544.90
Q04 20202.502.7911.60
Q03 20202.052.207.32
Q02 20202.282.5511.84
Q01 20202.632.650.76
Q04 20193.303.310.30
Q03 20193.053.080.98
Q02 20192.572.590.78
Earnings Per EndEstimateRevision %Trend
3/2021 QR3.05-6.73Negative
6/2021 QR2.59-14.52Negative
9/2021 FY12.812.48Positive
9/2022 FY13.420.22Positive
Next Report Date6th May 2021
Estimated EPS Next Report3.05
Estimates Count10
EPS Growth Next 5 Years %9.00
Volume Overview
Volume965.91K
Shares Outstanding290.56M
Trades Count18.77K
Dollar Volume390.86M
Avg. Volume1.30M
Avg. Weekly Volume1.02M
Avg. Monthly Volume1.09M
Avg. Quarterly Volume1.30M

Becton Dickinson and Company (NYSE: BDX) stock closed at 250.7 per share at the end of the most recent trading day (a 1.33% change compared to the prior day closing price) with a volume of 974.75K shares and market capitalization of 72.84B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 72000 people. Becton Dickinson and Company CEO is Thomas E. Polen.

The one-year performance of Becton Dickinson and Company stock is 1.05%, while year-to-date (YTD) performance is 0.19%. BDX stock has a five-year performance of 59.69%. Its 52-week range is between 219.5 and 284.97, which gives BDX stock a 52-week price range ratio of 47.66%

Becton Dickinson and Company currently has a PE ratio of 46.90, a price-to-book (PB) ratio of 2.86, a price-to-sale (PS) ratio of 5.15, a price to cashflow ratio of 16.00, a PEG ratio of 2.32, a ROA of 2.71%, a ROC of 4.73% and a ROE of 6.31%. The company’s profit margin is 10.21%, its EBITDA margin is 24.40%, and its revenue ttm is $13.95 Billion , which makes it $48.02 revenue per share.

Of the last four earnings reports from Becton Dickinson and Company, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $3.05 for the next earnings report. Becton Dickinson and Company’s next earnings report date is 06th May 2021.

The consensus rating of Wall Street analysts for Becton Dickinson and Company is Moderate Buy (2), with a target price of $281.62, which is +12.33% compared to the current price. The earnings rating for Becton Dickinson and Company stock is Neutral (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Becton Dickinson and Company has a dividend yield of 1.34% with a dividend per share of $3.32 and a payout ratio of 116.00%.

Becton Dickinson and Company has a Buy technical analysis rating based on Technical Indicators (ADX : 8.77, ATR14 : 5.96, CCI20 : 174.24, Chaikin Money Flow : 0.07, MACD : -2.09, Money Flow Index : 65.03, ROC : 3.71, RSI : 46.01, STOCH (14,3) : 94.11, STOCH RSI : 1.00, UO : 63.90, Williams %R : -5.89), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Becton Dickinson and Company in the last 12-months were: Claire M. Fraser-Liggett (Sold 1 542 shares of value $395 616 ), Patrick Kaltenbach (Sold 2 543 shares of value $640 189 ), Roland Goette (Option Excercise at a value of $267 090), Roland Goette (Sold 930 shares of value $213 993 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
7 (46.67 %)
7 (46.67 %)
7 (43.75 %)
Moderate Buy
1 (6.67 %)
1 (6.67 %)
1 (6.25 %)
Hold
7 (46.67 %)
7 (46.67 %)
8 (50.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
2.00
Moderate Buy
2.00
Moderate Buy
2.06

Becton Dickinson and Company

Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.

CEO: Thomas E. Polen

Telephone: +1 201 847-6800

Address: 1 Becton Drive, Franklin Lakes 07417-1880, NJ, US

Number of employees: 72 000

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

100%0%

Bearish Bullish

61%39%

Bearish Bullish

61%39%

Bearish Bullish

62%38%

News

Stocktwits